ALG.APV-527

· Aptevo Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALG.APV-527, covering 2023-07-07 to 2023-07-07. Get the full timeline:

Most recent: Clinical Trial Update: ALG.APV-527 First-in-human Study [Phase 1, Phase 2]